Trupanion, Inc. (NASDAQ:TRUP) Shares Purchased by Barclays PLC

Barclays PLC boosted its holdings in Trupanion, Inc. (NASDAQ:TRUP) by 259.2% during the third quarter, HoldingsChannel.com reports. The fund owned 65,498 shares of the financial services provider’s stock after acquiring an additional 47,262 shares during the period. Barclays PLC’s holdings in Trupanion were worth $2,750,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. Wellington Management Group LLP boosted its position in Trupanion by 4.4% during the 3rd quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock valued at $142,475,000 after purchasing an additional 142,156 shares during the period. FMR LLC boosted its holdings in shares of Trupanion by 55,963.7% during the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after acquiring an additional 1,170,202 shares during the period. Marshall Wace LLP grew its position in shares of Trupanion by 11.9% during the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after acquiring an additional 116,496 shares during the last quarter. DF Dent & Co. Inc. increased its holdings in shares of Trupanion by 27.8% in the 3rd quarter. DF Dent & Co. Inc. now owns 367,871 shares of the financial services provider’s stock worth $15,443,000 after acquiring an additional 80,014 shares during the period. Finally, Renaissance Technologies LLC bought a new stake in Trupanion in the 2nd quarter valued at about $4,739,000.

Insiders Place Their Bets

In related news, Director Murray B. Low sold 2,000 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $52.67, for a total value of $105,340.00. Following the completion of the transaction, the director now owns 131,513 shares in the company, valued at $6,926,789.71. This trade represents a 1.50 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Fawwad Qureshi sold 9,867 shares of the business’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $53.08, for a total value of $523,740.36. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 28,405 shares of company stock worth $1,512,482. 5.50% of the stock is owned by insiders.

Trupanion Stock Up 2.5 %

Shares of TRUP stock opened at $51.00 on Wednesday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66. The stock has a market cap of $2.16 billion, a PE ratio of -159.38 and a beta of 1.61. The business’s fifty day moving average is $52.90 and its 200-day moving average is $43.02. Trupanion, Inc. has a 1 year low of $19.69 and a 1 year high of $57.90.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The company had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. During the same quarter last year, the firm posted ($0.10) EPS. The business’s revenue for the quarter was up 14.6% on a year-over-year basis. Equities analysts expect that Trupanion, Inc. will post -0.23 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have commented on TRUP. Bank of America raised their price target on shares of Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research note on Friday, September 20th. Piper Sandler lifted their target price on Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a research note on Thursday, October 31st. Northland Securities increased their price target on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research note on Thursday, October 31st. Finally, Stifel Nicolaus lifted their price objective on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $44.67.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.